Top Image
Advanced Centre for Treatment Research & Education in Cancer
Facebook Twitter Gmail
Banner Image
Science Sparks @ ACTREC
Date Image 8 June 2026 Vol. No. 15 ; Issue No.738
Publications

1. Pillai A, Ramaswamy A, Rao AR, Kumar A, Mittal K, Sehgal A, Dhekale R, Pawar A, Shetake A, Mahajan S, Daptardar A, Sonkusare L, Deodhar J, Ansari N, Vagal M, Mahajan P, Timmanpyati S, Nookala M, Gota V, Banavali SD, Prabhash K, Noronha V (2026). Screening for poor muscle strength in older Indian patients with solid tumor using SARC-F questionnaire and handgrip. Journal of Geriatric Oncology.

2. Shetty C, Singhavi HR, Nair S (2026). Gingivobuccal Cancers: Demographics and Geographic Variations. Oral and Maxillofacial Surgery Clinics of North America.

3. Sachdev S, Cheloha RW (2026). Multivalent antibody-based conjugates as new tools for tailored modulation of G protein-coupled receptors. British Journal of Pharmacology.

4. Pal D, Govil D, Pachisia AV, Soni KD, Gupta S, Kothekar AT, Clerk AM, Srinivasan S, Kumar V, Gurav SK, Patel R, D'Costa PM, Prajapati AM, Shelgaonkar J, Karanth S, John JK, Toraskar K, Patel SJ, Savio RD, KN J, Harne R, Pandit RA, Mishra RC, Pande RK, Samavedam S, Singh YP, Myatra SN, Bhattacharya PK, Jagiasi BG, Jose C. Practice pattern of critical care ultraSonography in India (POCUS India): A multicenter cross-sectional survey. Indian Journal of Critical Care Medicine. 30 (5): 398-407.

5. Redhu AK, Gota V (2026). Ethnopharmacology in contemporary cancer research: Systems perspectives and translational opportunities. Systems Ethnopharmacology and Sustainable Bioresources.

6. Chaudhari P, Bendale K, Bhere S, Puri A, Gera P, Rane S (2026). Sclerotherapy for aneurysmal bone cyst in canine. Veterinary Medicine and Science.12(4):e70999.

7. Banerjee A, Mishra SV, Dsouza CA, Salunkhe S, Chandrani P, Dutt S (2026) Discovery of BEND4 as a novel single-gene prognostic marker and therapeutic target for adverse AML. NPJ Precision Oncology.

8. Das P, Das N, Narula G, Trehan A, Bakhshi S, Radhakrishnan V, Seth R, Tembhare P, Sachdeva MU, Chopra A, Sundersingh S, Das S, Gogoi M, Parihar M, Bhattacharya R, Banavali S, Saha V, Krishnan S (2026). Toxicity during induction of pulsed versus continuous prednisolone in children with acute lymphoblastic leukaemia: a multi-centre, open label, randomised, phase 3 trial from India (2016–2022). The Lancet Regional Health - Southeast Asia.

Site of the Week

WikiPathways is an open, collaborative platform dedicated to the curation of biological pathways.

desktop Image
Interesting Reads

Hajjar R, Mars RAT, Kashyap PC (2026). Harnessing the microbiome for cancer therapy. Nature Reviews Microbiology.

Video of the Week
Evolving role of HER2/ERBB2 targeting in Colorectal cancer
Upcoming Events
Bridging Evidence and Practice: A Hands-on Workshop on Implementation Research in Public Health.

June 15-17, 2026

At ACTREC, Tata Memorial Centre

Biomarker Applications to Inform Cancer Prevention

June 25-27, 2026

Online Workshop, by ACTREC, Tata Memorial Centre

A workshop on Basics of NGS Data Analysis

June 24-25, 2026

At ACTREC, Kharghar, Navi Mumbai

Do You Know?

In, 1903 S.W. Goldberg and Efim London first used radiation therapy to cure cancer. They made use of radium to treat two patients with basal cell carcinoma of the skin.

back Image
Cancer News
Blood protein signature can predict lung cancer risk before diagnosis

News-Medical, 04/06/2026

The team applied machine learning to blood plasma protein data from more than 48,000 UK Biobank participants, using matched cancer registry records to identify those who later developed lung cancer...

Scientists finally crack an “undruggable” pancreatic cancer target and nearly double survival.

Sciencedaily, 04/06/2026

A new drug, daraxonrasib, targets the KRAS mutation that fuels most pancreatic tumors—something many scientists once thought couldn't be done. In a major clinical trial, the treatment nearly doubled survival for patients with advanced disease and reduced the risk of death by 60%...

Oral drug combination eases treatment burden for AML patients.

EurekAlert, 03/06/2026

The nonrandomized phase 1/phase 2 study enrolled 189 newly diagnosed AML patients at centers across the United States, Canada and Spain. The patients took a month of venetoclax, along with five days of decitabine-cedazuridine at the start of each treatment cycle...

2026 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)